000 01378 a2200409 4500
005 20250516084634.0
264 0 _c20120723
008 201207s 0 0 eng d
022 _a1488-2353
024 7 _a10.25011/cim.v35i2.16293
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlmalki, Mussa H
245 0 0 _aManagement of prolactinomas during pregnancy -- a survey of four Canadian provinces.
_h[electronic resource]
260 _bClinical and investigative medicine. Medecine clinique et experimentale
_cApr 2012
300 _aE96-104 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBritish Columbia
650 0 4 _aCanada
650 0 4 _aDisease Management
650 0 4 _aDopamine Agonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNew Brunswick
650 0 4 _aNova Scotia
650 0 4 _aPregnancy
650 0 4 _aPrince Edward Island
650 0 4 _aProlactinoma
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aYoung Adult
700 1 _aUr, Ehud
700 1 _aJohnson, Michelle
700 1 _aClarke, David B
700 1 _aImran, Syed A
773 0 _tClinical and investigative medicine. Medecine clinique et experimentale
_gvol. 35
_gno. 2
_gp. E96-104
856 4 0 _uhttps://doi.org/10.25011/cim.v35i2.16293
_zAvailable from publisher's website
999 _c21671648
_d21671648